Archive | January, 2007

HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor.

2007 Jan;6(1):173-83. HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor. Kogan NM1, Schlesinger M, Priel E, Rabinowitz R, Berenshtein E, Chevion M, Mechoulam R. Author information Abstract Anthracyclines, a large group of quinonoid compounds, are used to treat some forms of cancer. Although highly effective in cancer therapy, the mechanism of action of these compounds is not specific; they act on […]